Over the past decade, photocatalysis has developed into a powerful strategy for the
selective functionalization of molecules through radical intermediates. Besides the well …

Purpose Patients with relapsed or refractory acute lymphoblastic leukemia (ALL) have a
dismal prognosis. CD19 is homogenously expressed in B-precursor ALL and can be …

Abstract Approximately 30% to 50% of adults with acute lymphoblastic leukemia (ALL) in
hematologic complete remission after multiagent therapy exhibit minimal residual disease …

Despite improvements in first-line therapies, published results on the treatment of relapsed
adult acute lymphoblastic leukemia (ALL) show that prognosis is still poor. The aim of the …

Background Preclinical data and results from non-randomised trials suggest that the
multikinase inhibitor sorafenib might be an effective drug for the treatment of acute myeloid …

The best strategy for incorporating imatinib in front-line treatment of Ph+ acute lymphoblastic
leukemia (ALL) has not been established. We enrolled 92 patients with newly diagnosed …

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A
Study by the German Acute Myeloid Leukemia Page 1 Age-Related Risk Profile and …

Purpose The prognosis of elderly patients with acute myeloid leukemia (AML) is still dismal
even with intensive chemotherapy. In this trial, we compared the antileukemic activity of …

This largest prospective multicenter trial for adult patients with Burkitt lymphoma/leukemia
aimed to prove the efficacy and feasibility of short-intensive chemotherapy combined with …

Results: Patients with AML M3, M3v, or M4eo demon-strated a better outcome compared
with all other FAB subtypes (P<. 001); no prognostic difference was observed among other …